TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
- 23 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 15 (7), 818-828
- https://doi.org/10.1038/ncb2774
Abstract
Dysfunctional telomeres suppress tumour progression by activating cell-intrinsic programs that lead to growth arrest. Increased levels of TRF2, a key factor in telomere protection, are observed in various human malignancies and contribute to oncogenesis. We demonstrate here that a high level of TRF2 in tumour cells decreased their ability to recruit and activate natural killer (NK) cells. Conversely, a reduced dose of TRF2 enabled tumour cells to be more easily eliminated by NK cells. Consistent with these results, a progressive upregulation of TRF2 correlated with decreased NK cell density during the early development of human colon cancer. By screening for TRF2-bound genes, we found that HS3ST4-a gene encoding for the heparan sulphate (glucosamine) 3-O-sulphotransferase 4-was regulated by TRF2 and inhibited the recruitment of NK cells in an epistatic relationship with TRF2. Overall, these results reveal a TRF2-dependent pathway that is tumour-cell extrinsic and regulates NK cell immunity.This publication has 62 references indexed in Scilit:
- Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone MetastasesCell, 2012
- The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeatsCell Research, 2011
- Human telomeric proteins occupy selective interstitial sitesCell Research, 2011
- In Vivo Stoichiometry of Shelterin ComponentsOnline Journal of Public Health Informatics, 2010
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansThe Journal of Experimental Medicine, 2009
- Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesisThe EMBO Journal, 2007
- Short Telomeres Limit Tumor Progression In Vivo by Inducing SenescenceCancer Cell, 2007
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53‐dependent cellular senescenceEMBO Reports, 2007
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003